Gene · 10403
Papers2,370
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,370
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disruption of the standard kinetochore in holocentric Cuscuta species. | Proc Natl Acad Sci U S A | 2023 | 37192159 | PubTator, text mining | PubMed |
| Genes whose expressions in the primary lung squamous cell carcinoma are able to accurately predict the progression of metastasis through lymphatic system, inferred from a bioinformatics analyses. | Sci Rep | 2023 | 37185598 | PubTator, text mining | PubMed |
| [Progress in the Study of Spindle Assembly Checkpoint in Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2023 | 37183646 | PubTator, text mining | PubMed |
| An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma. | Front Oncol | 2023 | 37182175 | PubTator, text mining | PubMed |
| Feasibility and acceptability of remote smartphone cognitive testing in frontotemporal dementia research. | Alzheimers Dement (Amst) | 2023 | 37180971 | PubTator, text mining | PubMed |
| Immunological role and prognostic value of the SKA family in pan-cancer analysis. | Front Immunol | 2023 | 37180139 | PubTator, text mining | PubMed |
| Molecular mechanisms protecting centromeres from self-sabotage and implications for cancer therapy. | NAR Cancer | 2023 | 37180029 | PubTator, text mining | PubMed |
| The RPA-RNF20-SNF2H cascade promotes proper chromosome segregation and homologous recombination repair. | Proc Natl Acad Sci U S A | 2023 | 37155876 | PubTator, text mining | PubMed |
| NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma. | BMC Urol | 2023 | 37138262 | PubTator, text mining | PubMed |
| Coseismic river avulsion on surface rupturing faults: Assessing earthquake-induced flood hazard. | Sci Adv | 2023 | 37134168 | PubTator, text mining | PubMed |
| The role of kinetochore dynein in checkpoint silencing is restricted to disassembly of the corona. | Mol Biol Cell | 2023 | 37126397 | PubTator, text mining | PubMed |
| SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma. | Front Cell Dev Biol | 2023 | 37123398 | PubTator, text mining | PubMed |
| NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma. | iScience | 2023 | 37123230 | PubTator, text mining | PubMed |
| Deciphering the Prognostic and Therapeutic Significance of Cell Cycle Regulator CENPF: A Potential Biomarker of Prognosis and Immune Microenvironment for Patients with Liposarcoma. | Int J Mol Sci | 2023 | 37108172 | PubTator, text mining | PubMed |
| Identification of a gene expression signature associated with breast cancer survival and risk that improves clinical genomic platforms. | Bioinform Adv | 2023 | 37096121 | PubTator, text mining | PubMed |
| Identification of a novel spirocyclic Nek2 inhibitor using high throughput virtual screening. | Bioorg Med Chem Lett | 2023 | 37094724 | PubTator, text mining | PubMed |
| Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer. | Int J Oncol | 2023 | 37083075 | PubTator, text mining | PubMed |
| KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres. | Cell | 2023 | 37075754 | PubTator, text mining | PubMed |
| Targeted assembly of ectopic kinetochores to induce chromosome-specific segmental aneuploidies. | EMBO J | 2023 | 37063065 | PubTator, text mining | PubMed |
| Coordination between the Ndc80 complex and dynein is essential for microtubule plus-end capture by kinetochores during early mitosis. | J Biol Chem | 2023 | 37060995 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10403/papers?page=12